Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma - Wikidata - awgldk - TriplyDB

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

http://www.wikidata.org/entity/Q26827319

about

Apatinib for molecular targeted therapy in tumor Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitors Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials.Targeted therapies for treatment of renal cell carcinoma: recent advances and future perspectives.An overview of quinoline as a privileged scaffold in cancer drug discovery.Efficacy of targeted therapy for advanced renal cell carcinoma: a systematic review and meta-analysis of randomized controlled trials.Apatinib as targeted therapy for sarcoma.

P2860

Q26775828-759AD91C-3C33-464E-ABCB-2BAF4638C36E Q33888739-D21DC751-28AD-4827-B020-A6BA27C28DFB Q34405616-9940A212-6CB9-4DBD-9BD1-C111037377E4 Q38473672-BE40D02C-D565-402B-8FA1-AF5BB02CE6F3 Q39235281-2001B3BD-2061-4111-B730-E53E0EEDB6FF Q47358265-1399C0AA-FA2E-4477-AEB1-0952AAF45884 Q54977588-C99E5A72-9ADB-4EC4-858C-C7688189CDFE

P2860

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

http://www.wikidata.org/entity/Q26827319

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

@ast

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

@en

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

@nl

type

label

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

@ast

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

@en

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

@nl

prefLabel

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

@ast

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

@en

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

@nl

P1433

Q26827319-B30467CC-32F1-4D72-A33B-350DEF06D27C

P1476

Q26827319-427D9ACB-3266-49BE-87B6-EC668F169BAB

P2093

Q26827319-BB6BC661-34B4-4F86-81DE-6C93793F783C

P2860

Q26827319-0E9A152F-FA59-4F1C-BDF2-54C37CD8BE31

Q26827319-28DF4A86-1646-4ED1-9CDF-4B760090543A

Q26827319-2BCA4019-C667-43AA-B2F2-2377660DDCBD

Q26827319-33C1C94D-A25F-4F2C-AE94-4F593B41D546

Q26827319-52EEADAC-C871-4444-B8A5-EA8171A42E3D

Q26827319-5ABE7A64-189A-47B5-9394-55DA1895EA5A

Q26827319-5BBF1947-19D6-4DD8-86CC-0F210AAD920B

Q26827319-62721AE9-2713-49B5-A56A-39F7FC8C92E6

Q26827319-64C5EE58-B762-4D8C-9254-06B0C4AA0F97

Q26827319-6966DCB9-77E8-4A0F-8701-C73C4841A12B

P304

Q26827319-0D940836-EC48-4190-AC18-4D70FCFA4DE9

P31

Q26827319-18D17A13-B7B1-4047-BCDE-EC42E8781016

Q26827319-425F0508-AC10-44AF-8242-0BF33CF41FE7

P356

Q26827319-94070B93-BAB3-4F50-A405-754AF3DB694C

P407

Q26827319-637E6D82-6CCA-4680-968D-B63CEFE5BBBF

P478

Q26827319-7D53EEA0-4BAC-42BC-9F7B-BB14BD4B296A

P577

Q26827319-6C651783-63F4-4992-A62D-A4588DC86F95

Q26827319-8D014F91-9EF9-4663-8477-26230EC8FAD6

P5875

Q26827319-6295369E-2E37-4F24-9DB8-B8B4305C7235

P698

Q26827319-F9AFBAE5-FAD1-45E1-B06F-711DE9DFA137

P921

Q26827319-45A10669-664E-4CD0-91DF-D017AD6C7417

Q26827319-4B797959-896E-483F-B338-153EC39C493F

Q26827319-8189B2DF-EBCD-4D8B-AF59-CD5EE4542BC1

Q26827319-8A3F3626-6E6D-43D6-B05E-5AE5A90A2A36

Q26827319-9137C131-16EC-479C-AD50-02BC607CFF8C

Q26827319-9F4E52B7-DB93-43B9-AF71-52E3AA69C66D

Q26827319-A6C649F6-3BDC-4BE1-AEDC-9D760A02EDAC

Q26827319-B55D6A7B-0C14-432B-82BE-25777085C031

Q26827319-C9559C5F-6BE4-4C1E-94ED-CFCFBFD17400

Q26827319-E9649E53-608A-47F9-93DD-F119F50192B7

P932

Q26827319-3B3960E1-A5AD-4398-9F20-2979E134D60A

P356

P1433

Drug Design, Development and Therapy

P1476

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

@en

P2093

Lance Cowey

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer treatment and survivorship statistics, 2012

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Sorafenib in advanced clear-cell renal-cell carcinoma

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206

Systemic therapy for renal cell carcinoma.

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

P304

519-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S31442

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2013-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

244482834

http://www.w3.org/2001/XMLSchema#string

P698

23818763

http://www.w3.org/2001/XMLSchema#string

P921

renal cell carcinoma

kidney neoplasm

heterocyclic compound

cell surface receptor

mechanism of action

membrane proteins

P932

3693745

http://www.w3.org/2001/XMLSchema#string